The data support drug development programs targeting PERK and other members of this pathway for the treatment of prion, and potentially other UPR-inducing, neurodegenerative diseases such as Alzheimer and Parkinson diseases. The gene discussed is EIF2AK3; the disease is Parkinson disease.